|
|
|
Overview
Drug development in China is a complex activity that involves a vast array of talents and resources. The process requires medical and laboratory expertise, as well as a variety of specialists in toxicology, preclinical evaluation, clinical trial design and implementation, and biologics production. Data and information systems managers maintain the flow of information to the Chinese regulatory bodies, while specialists in health economics and other fields may be consulted to interpret and prepare the market into which new drugs will be introduced. RAX is recognized by the pharmaceutical industry as the leading Clinical Research Organization (CRO) in China. We provide a full range of medical registration services including product registration, project management and monitoring for Phase I to IV registration and global trials, patient recruitment, data management, statistic analysis, and consulting services related to clinical trials (such as market assessment of products and clinical trial consulting). Our staff and consultants have extensive experience and a track record of achievements in these various areas. In addition, we provide product development
services to the medical device industry. RAX Consulting has assisted
many pharmaceutical, medical device and biologics companies successfully
meet regulatory requirements as well as their own business objectives.
|
